Understand the HPV Vaccine and Cervical Cancer Screening

Cervical cancer is largely preventable through HPV vaccination and regular cervical cancer screening, yet it remains a serious public health concern in India. The HPV vaccine, combined with regular cervical cancer screening, forms the core of prevention. The World Health Organisation has established an elimination strategy that targets the vaccination of 90% of girls by age 15 and screening of 70% of women by ages 35 and 45^[1]. This article covers when to get the HPV vaccine, what side effects to expect, why screening remains necessary even after vaccination, and what happens during a first screening appointment.

HPV Vaccine Age Recommendations: Why Timing Matters

Getting the HPV vaccine at the right age makes a significant difference to how well it works. India has recently introduced HPV vaccination into selected government immunisation programmes, and implementation is expanding across states. International guidelines commonly recommend routine vaccination at 11–12 years (starting as early as age 9), while Indian programmes primarily target girls aged 9–14 years. The reason early vaccination is preferred is straightforward: the vaccine works best before a person is exposed to HPV. Once exposure has occurred, the vaccine cannot treat an existing infection^[2].

According to the CDC, for those who miss vaccination during the routine window, catch-up vaccination is recommended through age 26. The number of doses also depends on age at the first dose^[2]:

• Two doses are usually sufficient when vaccination begins before age 15.

• Three doses are recommended when vaccination begins at age 15 to 26, or in people who are immunocompromised.

For adults aged 27 to 45, the situation is more nuanced. Some individuals in this age group may still benefit from getting the vaccine, but vaccination is not routine for everyone because average benefit is lower once HPV exposure becomes more likely^[3]. A clinician can help weigh the individual's circumstances before making a decision.

Understanding the Cervical Cancer Vaccine Age Limit

Many people assume there is a strict upper age beyond which the HPV vaccine offers no benefit. In practice, there is no absolute cut-off, but the benefit does vary based on prior exposure^[3].

Adults who are already sexually active, or even those who may have been exposed to HPV, may still gain protection against HPV types they have not yet acquired. However, an important limitation applies: the vaccine does not cure an existing HPV infection and cannot reverse abnormal cervical cell changes or Pap test results^[3].

The decision for adults, particularly those aged 27 to 45, is best made in consultation with a doctor who can assess factors such as likelihood of future HPV exposure, immune status, and overall risk profile. This is not a one-size-fits-all recommendation.

HPV Vaccination After Sexual Activity: What People Should Know

One of the most persistent misconceptions about the HPV vaccine is that it is only useful for people who have never been sexually active. This is not accurate.

The vaccine does not treat an existing HPV infection or any related disease that has already developed. It cannot clear an infection already present in the body. However, sexually active people may not yet have been exposed to all the HPV types covered by the vaccine. If future exposure remains possible, vaccination may still provide protection against HPV types the person has not yet encountered^[3].

This means the decision to vaccinate after becoming sexually active should still be discussed with a doctor. Age, prior exposure history, and future risk all play a role in determining whether vaccination is likely to be beneficial at that point.

HPV Vaccine Side Effects: Common Concerns and Safety Information

The HPV vaccine is generally well tolerated, and most reported side effects are mild and short-lived. Common side effects include^[4]:

• Pain, redness, or swelling at the injection site

• Fever

• Headache or tiredness

• Nausea

• Muscle or joint pain

These effects typically resolve on their own within a day or two.

Serious reactions are rare. Symptoms that require urgent medical attention include hives, swelling of the face or throat, difficulty breathing, a fast heartbeat, dizziness, or unusual weakness^[4]. These may indicate a severe allergic reaction and should be treated as a medical emergency.

Ongoing safety monitoring continues through surveillance systems such as AEFI (Adverse Events Following Immunisation), which track adverse events following vaccination across large populations. This monitoring helps ensure that any emerging safety signals are identified quickly.

If you experience any unusual or persistent symptoms after vaccination, contact a healthcare provider promptly.

Why Parents and Young Adults Often Delay HPV Vaccination

Despite the protective benefits, HPV vaccination rates remain lower than recommended in many settings, including India. Research points to several common reasons for delay.

Parents and young adults often have safety concerns, driven in part by misinformation about the vaccine's effects. Low awareness of how the vaccine works and what it protects against also plays a role^[5].

Social stigma is another significant barrier. Because HPV can be sexually transmitted, some parents believe their child is "too young" to receive a vaccine associated with a sexually transmitted infection^[6]. This misconception can delay vaccination well past the most effective age window, reducing its benefit.

Open conversations with a trusted healthcare provider can help address these concerns with accurate information rather than assumptions.

HPV Vaccination and Cervical Cancer Screening: Why One Does Not Replace the Other

Vaccination and screening serve different purposes. Understanding both is important for long-term cervical health.

The HPV vaccine prevents new HPV infections but does not protect against every cancer-causing HPV type. For this reason, vaccinated women should continue to follow the same cervical cancer screening recommendations as unvaccinated women^[3]. Screening can detect abnormal cervical cell changes early, even in women who have been vaccinated.

In India, the Ministry of Health and Family Welfare's population-based programme targets all women aged 30–65 years for cervical cancer screening. Women are screened once every 5 years, primarily using visual inspection with acetic acid (VIA), with HPV DNA testing being introduced as the newer primary screening method in parts of the programme^[7]. Women who are eligible should discuss their screening options with a healthcare provider, regardless of vaccination status.

Vaccination reduces risk; screening detects early changes. Both are needed for the most complete protection.

Cervical Cancer Screening: What to Expect During Your First Test

First-time cervical screening can feel daunting, but understanding the process often helps ease anxiety.

The appointment typically involves undressing from the waist down and lying on an examination bed. A healthcare provider inserts a small instrument called a speculum, then collects cervical cells using a soft brush. The test itself usually takes under five minutes, and the full visit is around ten minutes^[8].

If you are nervous or uncomfortable, you can ask for the following^[8]:

• A smaller speculum

• A different position

• A pause at any point during the procedure

Light spotting after the test is common. However, heavy bleeding or bleeding that continues beyond a day should be reviewed by a doctor. If your result is abnormal, this does not necessarily mean cancer; it usually means your doctor will recommend a follow-up test, such as a colposcopy, to look more closely at the cervix^[8].

Key Questions to Discuss With Your Doctor About HPV Vaccination and Screening

Coming prepared to your appointment can make the conversation more productive. Useful topics to raise include:

• Your age at first vaccination and how many doses you have received^[2]

• Whether catch-up vaccination is still appropriate for your age and health status^[2]

• Your immune status and whether it affects dose recommendations^[9]

• Whether a missed dose requires restarting the series, which it generally does not^[9]

• Your cervical screening eligibility and how often you should be screened^[7]

• Any symptoms, history of HPV infection, or individual risk factors relevant to cervical health^[3]

Being open about your health history helps your doctor give you guidance tailored to your circumstances.

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The information provided should not be used for diagnosing or treating health conditions. Always consult a qualified healthcare provider for diagnosis, treatment, and personalised medical advice. Do not disregard professional medical advice or delay seeking it because of information found in this article. If you have a medical emergency, contact your doctor or emergency services immediately.